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Summary
Objective: Regeneration of hyaline cartilage has been the focus of an increasing number of research groups around the world. One of the
most important outcome measures in evaluation of its success is the histological quality of cartilaginous tissue. Currently, a variety of histo-
logical scoring systems is used to describe the quality of osteoarthritic, in vivo repaired or in vitro engineered tissue. This review aims to pro-
vide an overview of past and currently used histological scoring systems, in an effort to aid cartilage researchers in choosing adequate and
validated cartilage histological scoring systems.
Methods: Histological scoring systems for analysis of osteoarthritic, tissue engineered and in vivo repaired cartilage were reviewed. The chro-
nological development as well as the validity and practical applicability of the scoring systems is evaluated.
Results: The Histological-Histochemical Grading System (HHGS) or a HHGS-related score is most often used for evaluation of osteoarthritic
cartilage, however the Osteoarthritis Research Society International (OARSI) Osteoarthritis Cartilage Histopathology Assessment System
seems a valid alternative. The O’Driscoll score and the International Cartilage Repair Society (ICRS) II score may be used for in vivo repaired
cartilage. The ‘Bern score’ seems most adequate for evaluation of in vitro engineered cartilage.
Conclusion: A great variety of histological scoring systems exists for analysis of osteoarthritic or normal, in vivo repaired or tissue-engineered
cartilage, but only few have been validated. Use of these validated scores may considerably improve exchange of information necessary for
advances in the ﬁeld of cartilage regeneration.
ª 2009 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The histological quality of cartilage is considered to be one of
the most important outcome tools to objectify severity of
cartilage pathology and success of its treatment1e3. Over
the past decades, as knowledge on osteoarthritis (OA),
in vivo repaired and tissue-engineered cartilage increased,
the number of systems evaluating histological characteristics
of these cartilaginous tissue types increased simultaneously.
One of the earliest systems for the grading of ‘OA carti-
lage’ was developed in 1949 by Collins and McElligott4,
who proposed a macroscopic system for classiﬁcation of
osteoarthritic changes of the human patella. This macro-
scopic system was succeeded by a microscopic system
for analysis of OA cartilage by Mankin in 1971, who devel-
oped the now well-known Histological-Histochemical Grad-
ing System (HHGS5). From then, methods enabling study of
cartilage characteristics in vitro as well as in vivo expanded,
and in 1986 O’Driscoll et al.6 presented a scoring system for
analysis of a ‘new’ type of cartilaginous tissue, commonly
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12The ﬁrst report on successful cartilage regeneration in
human clinical practice was presented in 1994 by Brittberg
et al.1, and the hyaline-like characteristics of the repaired
tissue inspired researchers world-wide to further improve
results from this procedure. Consequently, yet another
category of cartilage histology developed, being that of
the ‘tissue engineered’ cartilage.
While introduction of new scoring systems in all cate-
gories continued7e9, and in part due to disadvantages of
earlier systems10,11, the Osteoarthritis Research Society
International (OARSI) as well as the International Cartilage
Repair Society (ICRS) established committees to develop
standardized histological grading systems for qualitative
description of various cartilage characteristics8,12.
The variety of available scoring systems in the ﬁeld of car-
tilage research may obscure the choice of the appropriate
scoring system for a speciﬁc research setting. Further, it is
often not clear which system should be applied to answer
a speciﬁc research question, nor is it clear if a scoring system
has been validated for this application. Thismay be important
when comparing one’s results to that of other cartilage
researchers, orwhenaiming at validatingmethods to analyze
proteoglycan content of cartilage non-invasively13.
This review provides an overview of existing histological
scores for evaluation of osteoarthritic, in vivo repaired,
and in vitro regenerated cartilage, and discusses validity
and applicability of each of these systems (Fig. 1).
Fig. 1. Chronological development of cartilage histological scores after the ﬁrst macroscopical score in 1949 (Collins). OA scores are
presented in blue, in vivo cartilage repair scores in red, and in vitro tissue engineering scores in green.
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A system for evaluation of cartilage histological properties
should be comprehensive but also applicable to re-
searchers with only basic knowledge of (cartilage) histol-
ogy, regardless of the tissue type analysed. Intra- as well
as inter-observer variation should be low and the score sys-
tem is preferably validated. The importance of various char-
acteristics for the ideal cartilage scoring system when
developing a scoring system for in vivo repaired cartilage
was recognized by Pritzker and was summarized as ‘sim-
plicity, utility, scalability, extendibility and comparability’12.
Further, each scoring system should be used for its desig-
nated tissue type: scoring systems for OA cartilage should
focus on degenerative features of healthy or diseased
(OA) tissue, scoring systems for in vivo cartilage repair
should focus on the degree in which a cartilage defect is
successfully repaired, and scoring systems for tissue-engi-
neered cartilage should focus on the quality of newly gener-
ated cartilage after in vitro cartilage tissue engineering.
Before choosing which scoring system is to be used,
some basic knowledge of tissue pre-treatment and subse-
quent staining characteristics is required. To enable visual-
ization of cartilaginous tissue, an ethanoleformaldehyde
ﬁxation most adequately preserves morphology14. Glycos-
aminoglycans are best visualized using a ‘Safranin-O’ stain-
ing15. When used in combination with a ‘Fast-Green FCF/
Hematoxylin’ counterstaining, collagens and cell nuclei
may be visualized as well. The ‘Alcian Blue’ staining also
stains glycosaminoglycans, but has been reported to yield
less reproducible results. In combination with a ‘Picrosirius
Red’ staining, the Alcian Blue staining may visualize collag-
enous structures16. For both the Safranin O as well as the
Alcian Blue staining, incorporation of control cartilage sam-
ples during the histochemical staining process prevents
over- or underestimation of the glycosaminoglycan content
due to variation in ﬁxation and staining circumstances.
A variety of tissue characteristics may be assessed by
a scoring system after histological staining of the tissue.
Each characteristic may be scored separately in a quantita-
tive fashion, or in combination with other characteristics in
a categorical fashion, which may inﬂuence the statistical
design and evaluation of the experiment. In a quantitative
score, features considered important by the designer of
the score like ‘structure of the tissue’ or ‘proteoglycan con-
tent’, may be emphasized through a higher contribution to
the eventual score5. The resulting score may thus constitute
the sum of the individual parameters, for example: a tissueis scored as ﬁve out of a maximum of eight points, if two
points are obtained for ‘intensity of Safranin-O staining’,
two points for ‘cellularity’, and one point for ‘structural integ-
rity’. The score may also be the result of multiplication of the
abovementioned sum of parameters with ‘stage’ (extent of
the involved cartilage surface)12, thus obtaining a score de-
scribing the entire tissue area. Quantitative scores with
a broad numerical range like the O’Driscoll score for in
vivo repaired cartilage17, may increase the likelihood of ﬁnd-
ing statistically signiﬁcant differences between different
groups, but may also be susceptible to a larger inter-
observer variation.
Only few of the currently existing scoring systems have
been ‘validated’. Using a validated scoring system improves
reliability of observations and improves comparability of
these observations with results from other research groups.
It is therefore important to know not only if a score has been
validated, but also how the ‘validation’ was performed. Val-
idation of a score may occur through comparison to already
validated macroscopic scoring systems11, to other already
validated histological systems18, to automated (and vali-
dated) histomorphometric systems9 or to biochemical
parameters7. Of these validation methods, correlation to
proteoglycan content (‘biochemical parameters’) is often
considered important, as proteoglycan content is consid-
ered one of the major features of cartilage integrity in
healthy, repaired or tissue-engineered cartilage. Despite
the number of scoring systems, only the HHGS for OA car-
tilage and the Bern score for tissue-engineered cartilage
have been validated by biochemical analysis5,7.
Vice versa, existing histological scores have been used
as a tool to promote or validate emerging techniques analy-
sing cartilage quality, as for example radiographic measure-
ments19, magnetic resonance imaging (MRI)20,21 and new
T2 and T1 contrast-enhanced cartilage imaging techniques
as for example ‘delayed Gadolinium enhanced MRI of car-
tilage’ (dGEMRIC)22.
All ‘semi-quantitative’ histological scoring systems are
observer-dependent and thus subjective. Automated com-
puterized histomorphometry has been reported to enable
objective, accurate and reproducible analysis of cartilage
characteristics. However, use of computerized histomorph-
ometry may be limited by the high costs or by lack of tech-
nical expertise9,23.
This review was based on a search for literature in which
histological scoring systems were introduced, applied or
discussed. PubMed, Embase and Cochrane Library were
used for the search (syntax: histological AND (scoring*
14 M. Rutgers et al.: Histology scores for cartilage analysisOR grading* OR assessment* OR scale*) AND cartilage.
Last search: March 31st, 2009).Osteoarthritis (OA)HHGS/MANKIN SCOREThe HHGS or Mankin score for evaluation of osteoar-
thritic cartilage was originally proposed by Mankin in
19715, and although developed for the assessment of hu-
man articular cartilage it has also been used for grading
of animal cartilage. There is much confusion about the
use of the ‘Mankin score’, ‘HHGS’ or ‘modiﬁed Mankin
score’ (the last of which there are many). As Mankin in
1971 referred to his score as the ‘HHGS’, we have decided
to do the same. All other systems should be referred to as
a ‘modiﬁed Mankin system’ or a ‘modiﬁed HHGS’ with
speciﬁc remarks on the altered parameters.
The HHGS identiﬁes ‘cartilage structure’, ‘cell distribu-
tion’, ‘Safranin-O staining’ and ‘tidemark integrity’ as sepa-
rate subitems. The sum of the separate scores ranges
from 0 (normal) to 14 (severe OA). The HHGS was corre-
lated to a macroscopical score11, to biochemical parame-
ters and to 35SO4 incorporation
5. Although frequently
used, the HHGS score has been criticized for its question-
able reproducibility and inadequate assessment of ‘mild’
and ‘moderate’ OA10,11. Further, a lower score may result
from scoring features like ‘pannus’ and ‘surface irregulari-
ties’, characteristics which may also be found in healthy,
non-osteoarthritic tissue10. Moreover, the system does not
evaluate the extent to which the cartilage surface is affected
by the degenerative process12,18. As cartilage often
contains different regions with varying quality, omitting the
aspect of ‘extent’ may over- or under-estimate the overall
quality of the tissue. Moreover, the HHGS was demon-
strated to have a signiﬁcant intra- and inter-observer
variability10,11,18,24 (Table I).OARSI OSTEOARTHRITIS CARTILAGE HISTOPATHOLOGY
ASSESSMENT SYSTEMWith the objective to design a more useful method than
the HHGS to assess OA histopathology for wide application
in clinical and experimental OA assessment, the OARSI
Working Group developed the OARSI Osteoarthritis Carti-
lage Histopathology Assessment System12. The OARSI
system assesses the severity and the extent of cartilage
surface involvement in the local osteoarthritic process. In
contrast to the HHGS and most other OA scores, the
OARSI system emphasizes the extent of cartilage damageTable
Intra- and inter-observer va
Year Author Assessment
‘92 Van der Sluijs et al.24 Intra- and inter-observer variation
‘97 Ostergaard et al.10 Intra- and inter-observer
variation; validated against
macroscopical (Collins) score
‘99 Ostergaard et al.11 Intra- and inter-observer
variation; validation according
to macroscopical appearance
‘07 Custers et al.18 Intra- and inter-observer variation
comparison to OARSI systemover the articular surface through a ‘stage’ component, in
addition to damage analysed at several levels of the carti-
lage layer (i.e., ‘depth’ and ‘local cartilage damage’). ‘Grade’
(0 points for ‘normal’ up to six points for ‘severe’) and ‘stage’
(0 points for ‘no OA activity seen’ up to four points for
‘>50% of articular surface affected’) can be used separately
or can be combined in an overall score by multiplication.
The OARSI system was anticipated to be more adequate
for the assessment of mild OA and it was expected that
the OARSI system could be applied more consistently by
less experienced observers than the HHGS12. In a study
comparing the OARSI system with the HHGS, a similar re-
producibility was found, however the reliability of the OARSI
system was higher and indeed observer experience
seemed to be less important when using the OARSI sys-
tem18. Nevertheless, the authors reported that the staging
component of the OARSI system was difﬁcult to determine
with certainty due to the precision required for estimation of
the surface extent of osteoarthritic lesions12. This is demon-
strated in [Fig. 2(B)], where interpretation of ‘surface extent’
depends on which ‘grade’ is considered most important i.e.,
the irregular area in the superﬁcial zone of [Fig. 2(B)] is of
a higher ‘grade’ (grade 2.0) but present in only 10e25%
of the surface (stage 2) while areas with cell death (lower
‘grade’, i.e., grade 1.5) are present in more than 25% of
the cartilage surface (higher ‘stage’, i.e., Stage 3). Although
we used the OARSI system to illustrate differences in out-
come between HHGS and OARSI, the OARSI system has
not yet been validated for application on human articular
cartilage, nor has it been validated through correlation to
macroscopic or biochemical parameters [Fig. 2(AeC)].OTHER OA SCORESBesides the HHGS and the OARSI system, several other
simple systems have been used to grade OA19,25e31. These
scores are often referred to as ‘modiﬁed Mankin’ systems.
In essence, all of these systems assess similar parameters
as the HHGS, but the parameters are either scored in a dif-
ferent fashion, or an overall score is applied instead of sep-
arate subscores. Most of these scores were only used in the
study in which they were introduced, and none were vali-
dated (Table II).Cartilage repairO’DRISCOLL SCOREThe ﬁrst ‘cartilage repair’ score was used to assess the
quality of cartilage repair in rabbits after periosteal graftingI
riation of the HHGS
Result Comment
Adequate More strict criteria do not lead
to higher reproducibility
Inadequate HHGS inadequately discriminates
between macroscopically
normal and OA cartilage
Moderate HHGS is valid for normal and severe OA
cartilage, not for macroscopically mild
and moderate changes. Experience
not important.
; Excellent Reproducibility is experience-dependent
Fig. 2. Safranin O/Fast Green-stained histological sections of human knee articular cartilage (femoral condyle, 5 mm sections). Sections were
scored with the HHGS5 and with the OARSI scale12 in small (left) and larger magniﬁcation (right images, # and *). (A) Good quality cartilage of
a 45-year old male tissue donor without history of traumatic or inﬂammatory joint diseases. The surface is smooth without irregularities (*), and
the osteochondral junction is intact (#). (B) Moderate quality cartilage of a 57 year old female, obtained during an unicompartmental joint
replacement. Note the altered structure of the cartilage, the slight surface irregularities (*) and the onset of cell clone formation (#).
(C) Low quality cartilage obtained during a total knee replacement with ﬁbrous tissue characteristics, demonstrating matrix loss, surface
abrasions (*) and extensive cloning (#).
15Osteoarthritis and Cartilage Vol. 18, No. 1of cartilage trauma6,17. This score speciﬁc for cartilage re-
pair, which is now often referred to as the O’Driscoll score,
encompassed four major categories (‘nature of the predom-
inant tissue’, ‘structural characteristics’, ‘freedom from cellu-
lar changes of degeneration’ and ‘freedom from
degenerative changes in adjacent cartilage’) and was fre-
quently used for cartilage analysis in animal studies32e34.
A high intra- and inter-observer reproducibility was demon-
strated, when used to analyze goat articular cartilage35.
However, many different subitems make it a somewhat
lengthy score. The O’Driscoll score is one of the few scores
in which ‘integration’ of the repair tissue with its surround-
ings is assessed [Fig. 3(A, B)], however the additionally
added (or subtracted) points do not greatly affect the even-
tual score. The O’Driscoll score has frequently been used in
modiﬁed versions (Table III).PINEDA SCALEIn an effort to create a more compact score to evaluate
cartilage repair, Pineda et al.36 developed a new system
which was applied to assess the natural healing capacity
of defects drilled into rabbit knee articular cartilage. The
Pineda scale contains four categories: ‘percent ﬁlling of
the defect’, ‘reconstitution of osteochondral junction’, ‘matrix
staining’ and ‘cell morphology’. Although it was hypothe-
sized that a simple score as the Pineda scale would have
a higher reproducibility than the O’Driscoll score, the more
comprehensive O’Driscoll score demonstrated a similar
intra- and inter-observer variation. The correlation with the
Pineda scale was high (correlation coefﬁcient of 0.71)35.
A commonly used modiﬁcation of the Pineda scale was
introduced in 1994 by Wakitani et al.37 to study the
Table II
Modifications of the HHGS and other OA scores
Year Authors Comment
‘69 Otte30 Also known as ‘Fassbender’; modiﬁed by Saal et al.19. Only grades cartilage surface structure. High
correlation with ‘surface structure’ category of HHGS
‘83 Colombo et al.26 The Colombo score is similar to the HHGS and was modiﬁed by Hotta et al.67
‘87e‘07 Several68e82 Varying modiﬁcations, however ‘tidemark integrity’ is a frequently discussed or excluded category
‘91e‘97 Bendele and Hulman25,
Fremont et al.28,
Huang et al.29
These scores directly apply an overall score of severity to the cartilage section. Bendele includes a
staging component. Huang classiﬁes into 4 grades: Grade II, for example, comprises ﬂaking,
superﬁcial ﬁbrillation, chondrocyte enlargement and hyalinization.
‘94 Foland et al.27 Measures ﬁbrillation, chondrocyte necrosis, chondrone formation and focal loss of cells. Modiﬁed by
Frisbie et al.83.
‘05 Yagi et al.31 Scores matrix depletion and cellularity quantitatively
16 M. Rutgers et al.: Histology scores for cartilage analysischaracteristics of repaired full-thickness cartilage defects in
rabbits. This ‘Wakitani score’ assesses ‘surface regularity’,
‘thickness of reparative cartilage compared with surround-
ing cartilage’ and ‘integration of donor cartilage with adja-
cent cartilage’, instead of ‘percent ﬁlling of the defect’ and
‘reconstitution of osteochondral junction’ in the O’Driscoll
score. Both the Pineda and Wakitani score have been mod-
iﬁed frequently38e44, however solely the Pineda scale was
validated35.THE OSWESTRY SCOREIn contrast to animal studies, study of articular cartilage
repair in humans is limited by availability and size of the bi-
opsy of the repaired tissue. For example, the category
‘bonding to the adjacent cartilage’ (O’Driscoll score) may
only be scored when a biopsy is taken from a transitional
zone between ‘new’ and ‘old’ cartilage, requiring either
a large biopsy or a full joint explant. This issue was recog-
nized by Roberts et al.20, and as harvesting of large size bi-
opsies including this transitional zone is usually not
desirable as this may affect repair of the damaged area,
the authors proposed a grading system for small biopsies
of repaired human cartilage. The subsequently developed
‘OsScore’ comprises seven parameters (‘tissue morphol-
ogy’, ‘matrix staining’, ‘surface architecture’, ‘chondrocyte
clusters’, ‘mineral’, ‘blood vessels’ and ‘basal integration’)
and has a maximum score of 10 points. The OsScore dem-
onstrated a high inter-observer variability, and an excellent
correlation with the O’Driscoll score (r¼ 0.9)20.KNUTSEN SCOREIn addition to these scoring systems, less extensive scoring
systems were used for histological analysis of cartilage repair.
Knutsen et al.2 categorized cartilage biopsy samples using
a hematoxylineeosin staining and describes categories as ‘hy-
aline’ (60%hyaline cartilage), ‘ﬁbrocartilageehyalinemixture’
(40e60% hyaline cartilage), ‘ﬁbrocartilage’ (60% ﬁbrocartila-
ginous tissue) or as a sample ‘without repair tissue’. In 2000Pe-
terson et al.45, using multiple staining methods, used a similar
system to evaluate the results of the autologous chondrocyte
implantation (ACI), describing the tissue as ‘hyaline-like’,
‘ﬁbrous’ or ‘mixed’. Neither of these scores were validated.ICRSInterestingly, the ICRS Histological Endpoint Committee
introduced the ICRS Visual Histology Score in 2003, argu-
ing that for more easy and reliable comparison ofhistological assessment a system based on visual patterns
is preferable over a verbal description-based system8. A
web-based catalogue of cartilage repair images was set
up as a reference for scoring, and to enable discrimination
of the individually scored features, instead of summarizing
all the individual subscores (IeVI) to create a total score,
the score values (0e3) for the different categories (‘surface’,
‘matrix’, ‘cell distribution’, ‘cell population’, ‘subchondral
bone’, ‘cartilage mineralization’) are described in the ﬁnal
score (i.e., I:3; II:3; III:1; IV:2; V:1; VI:3). To our knowledge
no studies exist that have evaluated the validity and reliabil-
ity of the ICRS Visual Histology Score. However, the Os-
Score and the ICRS score were found to correlate fairly
well46. The ICRS VHS was modiﬁed by Chang et al.47, by
addition of categories for the staining of type I collagen
and type II collagen.
A new histological scoring system has been developed
and validated by the Histology Working Group of the
ICRS48,49. This ‘‘ICRS II’’ score addresses various aspects
of cartilage repair and was ﬁrst applied clinically in a large
prospective randomized trial in which the clinical and histo-
logical results of microfracture and ACI were compared3.
The ICRS II score contains several categories which are
subdivided in 13 categories each scored on a 100-mm vi-
sual analogue scale (VAS). A 100-mm VAS scale enables
evaluation of subtle differences and facilitates statistical
comparison of the individual cartilage characteristics50.
The categories of the ICRS II score are, besides ‘overall
assessment’ (badegood), ‘matrix-staining metachromasia’
(no metachromasia e full metachromasia), ‘tissue morphol-
ogy’ (ﬁbril presence viewed under polarized light; full-thick-
ness collagen ﬁbres e normal cartilage birefringence),
‘chondrocytes clusters’ (four or more grouped cells; absen-
tepresent), ‘calciﬁcation front/tidemark’ (no calciﬁcation
frontetidemark), ‘subchondral bone abnormalities/cellular
inﬁltration’ (abnormalenormal/no inﬁltrates), ‘architecture
of the surface’ (delamination/loosening/disruptionsesmooth
surface), ‘basal integration’ (no basal integrationebasal
integration), ‘cell morphology’ (no round/oval cellse
mostly round/oval cells), ‘abnormal calciﬁcation/debris’
(presenteabsent), ‘vascularisation within the repair tissue’
(presenteabsent), ‘mid-deep zone assessment’ (bade
good) and ‘surface/superﬁcial assessment’ (badegood)
(Fig. 3) (Table IV). A 14th category (‘inﬂammation’) may
be included when a scaffold has been used during the
cartilage repair procedure, as for example during matrix-
assisted chondrocyte implantation. Similar to most other
cartilage repair scores, this score does not evaluate integra-
tion of the repair tissue with its surroundings, which is due to
the often limited size of a biopsy in the clinical setting.
Fig. 3. Safranin O/Fast Green-stained histological sections of adult female Dutch Milk goat knee articular cartilage, after a microfracture pro-
cedure (5 mm sections). Sections were scored with the O’Driscoll score6 and the ICRS II score48 in small (left) and larger magniﬁcation (right
images, # and *). ICRS II score categories are abbreviated as follows: overall; staining; morphology; clusters; tidemark; subchondral bone;
surface architecture; basal integration; cells; abnormal calciﬁcation; vascularisation; mid deep zone; surface assessment. The microfractured
area is between the dotted lines. (A) High quality repaired cartilage; assessment of ‘bonding of the repaired cartilage with its surroundings’ is
possible with the O’Driscoll score, while the ICRS II score gives more detailed information about speciﬁc repair features as for example basal
integration. (B) Moderate quality repaired cartilage; the ICRS II score acknowledges the more intense overall Safranin-O staining in this sec-
tion [compared to the previous ‘high quality’ section, Fig. 3(A)] while the O’Driscoll score only provides a lower total score. Note the hyper-
cellularity in the microfractured part of the tissue (#) in comparison to the cellular cloning in the non-microfractured part (*). (C) Low quality
repaired cartilage; weak Safranin-O staining (#) and an absent tidemark are reﬂected in the ICRS II score, while these features are not dis-
cussed in the O’Driscoll score. While the overall O’Driscoll score of this section hardly differs from that of the previous section [Fig. 3(B)], sig-
niﬁcant differences exist between the ICRS II subcategories of these sections. Note the transition from Safranin-O stained tissue in the original
cartilage to non-stained tissue in the repaired cartilage (upper left of magniﬁcation *), and the poor binding of the cartilage to the subchondral
bone in the microfractured part (lower right of magniﬁcation *) compared to the non-repaired cartilage.
17Osteoarthritis and Cartilage Vol. 18, No. 1When comparing the O’Driscoll score and the ICRS II
score in Fig. 3, differences in ‘intensity of matrix staining’
are not reﬂected in O’Driscoll subscores, while the ICRS II
score does distinguish the more intense Safranin-O staining
in the ‘moderate’ quality tissue, even though the ‘good qual-
ity’ cartilage has a higher O’Driscoll score [Fig. 3(A, B)]. Fur-
ther, little difference exists between total O’Driscoll scores
for ‘moderate’ and ‘low’ quality repaired tissue [Fig. 3(B,
C)], while the ICRS II subscores are obviously different
(i.e., staining and basal integration).Tissue-engineered cartilage
As in OA and in vivo repaired cartilage, the quality of tis-
sue-engineered cartilage is described using macroscopic
morphological outcome parameters, immunohistochemical
staining, quantitative histomorphometry, analysis of overallcellularity, DNA content, glycosaminoglycan content and
collagen content23,51e56. Few histological scoring systems
are available for the evaluation of tissue-engineered
cartilage.
In 2001, O’Driscoll correlated a simple four-category sub-
jective scoring system to an automated histomorphometry
program determining the intensity of Safranin-O staining9.
The score, in essence a modiﬁcation of the Mankin score,
showed a good correlation with the automated system and
the authors suggest that this system is a good alternative to
a computerized system. However, this automated system
only focused on proteoglycan ‘density’, and did not evaluate
characteristics as, for example, cell morphology.
Another grading system developed exclusively for the
evaluation of in vitro engineered cartilage was presented
in 20067. This ‘Bern score’ showed a good correlation of
cartilage quality with glycosaminoglycan content as mea-
sured biochemically and by automated histomorphometry.
Table III
Most cartilage repair scores (other than the Pineda, Oswestry, Knutsen and ICRS scores) are based on modifications of the
O’Driscoll score or HHGS
Year Authors Comment
‘95e‘08 Several63,84e97 O’Driscoll category modiﬁcations; most important new or altered categories:
‘reconstitution of subchondral bone’, ‘tidemark formation’, ‘basal integration of the
graft’ and ‘signs of inﬂammation’
‘97e‘07 Several66,98e100 Includes a score which evaluates focal chondral defect treatment using a score based on
HHGS66. As the O’Driscoll score, this score evaluates cartilage repair integration.
Further, macroscopical evaluation is used in combination with histological evaluation
‘01 Mainil-Varlet et al.90 O’Driscoll category modiﬁcations; ‘chondrocyte clustering’ is considered as a
feature of repair tissue and not as a degenerative feature
‘08 Nettles et al.63 Combination of O’Driscoll score and ICRS I (Visual Histological Assessment Scale).
Although various ‘new’ scales combine features of earlier scales, this is one of the only
systems that explicitly combines 2 scales
18 M. Rutgers et al.: Histology scores for cartilage analysisThe Bern score was validated for the assessment of pellet-
cultured cartilage, and has been used several times thus
far57e61. Im et al.62 modiﬁed the Bern score by addition of
‘immunohistochemical staining for type II collagen’ to the
ﬁrst scoring parameter. The inﬂuence of this modiﬁcation
on the validity of the original score was not evaluated. An
advantage of the Bern score, is that it covers a broader
score range and thus gives more detailed information on
tissue characteristics, than for example the O’Driscoll score
(Fig. 4).
Discussion
Evaluation of cartilage quality through histological analy-
sis signiﬁcantly contributes to the assessment of the extent
of cartilage damage or the success of cartilage regenera-
tion1e3. The development of in vitro tissue engineering tech-
niques further extends knowledge of cartilage structure and
composition. When evaluating cartilage characteristics,
choosing the appropriate histological scoring system is im-
portant for analysis of cartilage pathology, evaluation of the
result of its in vivo treatment or for further in vitro tissue en-
gineering research. For each of these categories, different
histological scoring systems exist.Table I
Parameters assessed by some m
Parameters of the
different grading
systems
O’Driscoll
et al.6
Pineda
et al.36
Wakitani
et al.37
Cell morphology   
Matrix staining   
Surface regularity  
Structural integrity 
Thickness/defect ﬁlling   
Osteochondral junction  
Adjacent bonding  
Basal integration
Cellularity 
Clustering/distribution 
Adjacent cartilage
degeneration

Mineral
Blood vessels
Subchondral bone
Viability cell population
Inﬂammation
Cartilage plug qualityHealthy cartilage is most often distinguished from osteo-
arthritic cartilage using the HHGS5 or a HHGS-related
score, even though reproducibility and validity of this score
have been disputed10,11. Nevertheless, in our experience it
is an adequate system for analysis of degenerative cartilage
characteristics due to its overall comprehensive character.
The widespread use of this system further facilitates com-
parison of one’s histological data with that of other cartilage
researchers. The many modiﬁcations of the HHGS necessi-
tate the use of adequate terminology; ‘HHGS’ or ‘Mankin
score’ for the original 1971 score, and ‘modiﬁed Mankin’
or ‘modiﬁed HHGS’ for scores in which a modiﬁcation has
been made, even if only one category is omitted.
An alternative for the HHGS is the OARSI system12,
which seems easier in use for inexperienced scorers12,18
but has been used infrequently thus far. When the entire ar-
ticular surface is included in a tissue section, as for example
in joints of small animals, the inﬂuence of surface extent or
‘stage’ in the eventual score provides additional information.
As the OARSI system seems more robust and the reliability
is higher than the HHGS18, this system will be preferable in
most cases.
Of the various scores available for analysis of in vivo re-
paired cartilage, the ICRS II score49 seems most suitable,V
ajor cartilage repair scores
Modiﬁed
Mankin
(Uhl et al.)66
OsScore20 ICRS I
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et al.2
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Fig. 4. Safranin O/Fast Green-stained histological sections of tissue-engineered (TE) cartilage (healthy human knee articular chondrocytes,
passage 2, cultured for 28 days in medium containing transforming growth factor b2, 5 mm sections). Sections are scored using the Bern
score7 and the O’Driscoll score9. (A) TE cartilage of high quality; note the intense Safranin-O staining and high amount of matrix as well
as chondrocyte-like cells in the tissue. (B) TE cartilage of moderate quality; note the less intense Safranin-O staining and the combination
of ﬁbroblast-like cells and chondrocytes, resulting in a lower Bern score. (C) TE cartilage of low quality; a thin matrix and hardly any
Safranin-O staining leads to an even lower Bern score. The Bern score obviously facilitates more subtle distinction of slight changes in tissue
quality through its broader range (Bern score: 3e9 vs O’Driscoll: 0e3).
19Osteoarthritis and Cartilage Vol. 18, No. 1as it is validated, comprehensive and describes each carti-
lage characteristic individually. Further, this score proved
valuable during analysis of biopsies in the course of a recent
randomized controlled clinical trial3. As biopsies of human
cartilage are often small and do not include a border region
between repaired cartilage and its surroundings, one may
choose to comment on this separate from the score. Alter-
natively, the O’Driscoll score6 may be used.
For evaluation of in vitro engineered cartilage, the ‘Bern
score’7 is preferred as it is validated and adequately distin-
guishes between characteristics speciﬁc for tissue-engi-
neered cartilage57e61.
Sporadically, authors use two different histological scor-
ing systems in a parallel fashion, or combine the scoring
systems into one, in essence creating a new scoringsystem63. The difﬁculty of combining scoring systems is
that the mutual parameters of each scoring system (for ex-
ample: proteoglycan staining) are over-emphasized in the
eventual score, thus decreasing the ‘impact’ of separate
categories of the individual scores. Using scoring systems
in a parallel fashion results in more information on the his-
tological characteristics of the assessed tissue, however us-
ing one comprehensive validated system is preferable over
using several non-validated systems.
Although validation is one of the major motivations for the
application of a particular scoringmethod, the ideal validation
method remains disputable. Ideally, a histological score is
validated by comparison to several parameters important
to cartilage, i.e., by comparison to (validated) biochemical,
biomechanical, macroscopical and (functional) imaging
Fig. 5. Choice of an appropriate scoring system may be aided by a ﬂow diagram. Validated scores are presented in bold.
20 M. Rutgers et al.: Histology scores for cartilage analysistechniques. Of these parameters, regardless of the tissue
type (OA, repaired or tissue-engineered cartilage), correla-
tion to biochemical parameters seems important. Neverthe-
less, biomechanical properties are important for repaired
cartilage as well and biomechanical testing techniques as
for example ‘indentation stiffness’ may add to the qualitative
description of the tissue64. However, these techniques may
have their limitations (i.e., analysis of cartilage repair aftermi-
crofracture using indentation stiffness is limited due to out-
growth of subchondral bone)65. The ideal combination of
analysis techniques therefore remains to be developed. In
the future, not only uniformity in the application of histological
scores, but also in the use of validation techniqueswill aid de-
velopment of improved cartilage analysis techniques. Even
when adequately validated, additive information on macro-
scopical, biochemical and biomechanical aspects of the tis-
sue will yield a more complete picture of tissue quality64,66.
In conclusion, a variety of histological scoring systems ex-
ists for analysis of osteoarthritic or normal, in vivo repaired or
in vitro tissue-engineered cartilage, but only few have been
validated. For each category, speciﬁc validated histological
scores emerge as most suitable for application. Use of these
validated scoresmay considerably improve exchange of infor-
mation necessary for advances in the ﬁeld of cartilage regen-
eration and thus stimulate uniformity enabling comparison of
results of different cartilage research groups (Fig. 5).Conﬂict of interest
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